Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches

Table 1

Demographic and clinical characteristics of the study group, depending on different types of disease-modifying therapy.

Parameters	IFN-β	IFN-β1b
	22	17	5	7	12	10
Age [years]						—	0.27
Age at the beginning of [years]							0.38
Age [% of females]						60.0	0.62
Time of MS [months]						—	0.14
Time of DMT [months]						—	0.15
[score]						—	0.83
[]						—	0.58
T2 lesions (from the time of diagnosis) []						—	0.76
New MRI lesions (within the last year) []						—	0.52
MRI lesions (from the time of diagnosis) []						—	0.20
New Gd+ MRI lesions (within the last year) []						—	0.35

a: disease-modifying therapy; b: Expanded Disability Status Scale; c: annual relapse rate; d: magnetic resonance imaging; e: Gadovist; f: interferon beta; g: glatiramer acetate; h: natalizumab; i: fingolimod; j: control group.